Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Clinical use of biomarkers of survival in pulmonary fibrosis Thomeer M; Grutters JC; Wuyts WA; Willems S; Demedts MGRespir Res 2010[Jun]; 11 (1): 89BACKGROUND: Biologic predictors or biomarkers of survival in pulmonary fibrosis with a worse prognosis, more specifically in idiopathic pulmonary fibrosis would help the clinician in deciding whether or not to treat since treatment carries a potential risk for adverse events. These decisions are made easier if accurate and objective measurements of the patients' clinical status can predict the risk of progression to death. METHOD: A literature review is given on different biomarkers of survival in interstitial lung disease, mainly in IPF, since this disease has the worst prognosis. CONCLUSION: Serum biomarkers, and markers measured by medical imaging as HRCT, pertechnegas, DTPA en FDG-PET are not ready for clinical use to predict mortality in different forms of ILD. A baseline FVC, a change of FVC of more than 10%, and change in 6MWD are clinically helpful predictors of survival.|Biomarkers/blood[MESH]|Diagnostic Imaging/methods[MESH]|Exercise Test[MESH]|Humans[MESH]|Predictive Value of Tests[MESH]|Prognosis[MESH]|Pulmonary Fibrosis/blood/diagnosis/*mortality/physiopathology[MESH]|Respiratory Function Tests[MESH]|Risk Assessment[MESH]|Risk Factors[MESH]|Survival Analysis[MESH]|Time Factors[MESH] |